Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02822131Completed
Randomised, open-label trial (2 arms), sponsored by University of Zurich. Primary endpoints: Change in blood pressure at 5 days and Change in renal sodium chloride excretion at 5 days. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02822131.